Advanced T stage, N stage, and clinical stage had higher median pretreatment plasma EBV DNA levels; however, the differences did not reach statistical significance (all P > 0.05; Table 2 ).
← all excerpts
Clinical Implications of Plasma Epstein-Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.
1
0.0500
0.0500